Sort by
Refine Your Search
-
biopharmaceuticals. The research at CMB pushes the boundaries of biomolecular and bioinformatics research and engineering technologies. VIB.AI studies fundamental problems in biology by combining machine learning with
-
will reflect in its strategic focus the European political agenda of a dual (digital and green) transition and topics related to European sovereignty. Your role We are looking for 2 PostDocs who will
-
-Titan instruments, a dual beam FIB, an environmental SEM,... EMAT is also a pioneer in in situ 3D ED studies, as will be important in this project. More about us at our webpage . Position This postdoc
-
in (plant) molecular biology or biochemistry with max. 4 years of postdoc experience. You are an expert in molecular biology, biochemistry and/or (plant) biotechnology. You have guided (master/PhD
-
speak and write fluently in English. You comply with the FWO Postdoctoral fellowship eligibility criteria. You have not yet submitted an application for FWO and/or MSCA postdoc fellowships with
-
/microglia-based 3D models recapitulating neural-microglia interactions, using biomaterials and (micro)tissue engineering approaches. The innovative aspect of the project will be in developing new analysis
-
are looking for Postdoc candidates to join the team to contribute to our research agenda and to the excellence of the group and of SnT in general. Successful candidates are expected to participate in
-
-scale screens to study fundamental principles in molecular and complex trait genetics using microbes as model systems. Our core technology MAGESTIC (https://doi.org/10.1038/nbt.4137 ), a CRISPR/Cas9-based
-
About the FSTM The University of Luxembourg is an international research university with a distinctly multilingual and interdisciplinary character. The Faculty of Science, Technology and Medicine
-
-scale screens to study fundamental principles in molecular and complex trait genetics using microbes as model systems. Our core technology MAGESTIC (https://doi.org/10.1038/nbt.4137 ), a CRISPR/Cas9-based